Education and professional-certification platform founded in 2019 by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, providing training in psychedelic-assisted therapy and integration for clinicians and biotechs. Its programs cover ketamine-, psilocybin- and MDMA-assisted therapy and integration, and it maintains a searchable directory of trained therapists, reporting more than 8,000 clinicians trained.
Fluence News 5 articles
- Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
- Fluence Moves To Withdraw Trademark
- Fluence Raises $3 Million to Scale Psychedelic Therapy Training
- Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida
- Fluence: Training the Next Generation of Psychedelic Treatment Professionals